Unicharm (OTCMKTS:UNICY – Get Free Report) posted its quarterly earnings results on Wednesday. The company reported $0.04 EPS for the quarter, Zacks reports. Unicharm had a net margin of 6.33% and a return on equity of 6.85%.
Unicharm Stock Performance
Unicharm stock traded down $0.19 during mid-day trading on Wednesday, reaching $2.94. The company’s stock had a trading volume of 39,128 shares, compared to its average volume of 425,012. Unicharm has a 12-month low of $2.61 and a 12-month high of $3.67. The company has a market capitalization of $10.23 billion, a P/E ratio of 24.50 and a beta of 0.31. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.06 and a current ratio of 2.57. The firm’s fifty day moving average price is $2.92 and its two-hundred day moving average price is $3.01.
Wall Street Analysts Forecast Growth
Separately, Zacks Research downgraded Unicharm from a “strong-buy” rating to a “hold” rating in a research report on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to MarketBeat, Unicharm has an average rating of “Buy”.
About Unicharm
Unicharm Corporation is a Tokyo‐based consumer goods company founded in 1961. Specializing in hygiene and care products, the firm has built its reputation on developing innovative, high-performance solutions for everyday needs. Over more than six decades, Unicharm has grown from a domestic manufacturer to a leading global player in the personal care industry.
The company’s core business activities encompass the design, production and marketing of disposable hygiene products. Key product lines include baby care items such as diapers and training pants; feminine hygiene products including sanitary napkins and panty liners; adult incontinence solutions; and pet care offerings like pet diapers and wet wipes.
Featured Stories
- Five stocks we like better than Unicharm
- AMD’s Post-Earnings Drop May Be the Opportunity Investors Wanted
- 3 Stocks That Prove the AI Trade Isn’t Over, It Moved
- The FTC Is Suing Hims & Hers Health—Here’s Why Investors Shouldn’t Panic
- 3 Stocks Taking Very Different Routes Through the Summer Rally
Receive News & Ratings for Unicharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unicharm and related companies with MarketBeat.com's FREE daily email newsletter.
